Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Hunan Yongren Medical Innovation
Welcome,
Profile
Billing
Logout
1 Product
0 Diseases
1 Product
1 Trial
0 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells
/ Hunan Yongren Medical Innovation, Zhaotai InVivo Biomedicine
TGFβ targeting CAR-T cells
/ Hunan Yongren Medical Innovation, Zhaotai InVivo Biomedicine
zeushield cytotoxic T lymphocyte therapy
/ Hunan Yongren Medical Innovation, Hunan Zhaotai Yongren